These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8378077)

  • 1. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas.
    Tominaga O; Hamelin R; Trouvat V; Salmon RJ; Lesec G; Thomas G; Remvikos Y
    Oncogene; 1993 Oct; 8(10):2653-8. PubMed ID: 8378077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in colorectal adenomas.
    Kaklamanis L; Gatter KC; Mortensen N; Baigrie RJ; Heryet A; Lane DP; Harris AL
    Am J Pathol; 1993 Jan; 142(1):87-93. PubMed ID: 7678722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].
    Yang Y; Xia Q; Lian F
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):114-8. PubMed ID: 11776850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
    Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y
    Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives.
    Lohmann D; Ruhri C; Schmitt M; Graeff H; Höfler H
    Diagn Mol Pathol; 1993 Mar; 2(1):36-41. PubMed ID: 8287224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
    Saigusa N; Maruyama K; Sugimura H; Endoh Y; Baba S
    Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 alterations in chemically induced hamster cheek-pouch lesions.
    Gimenez-Conti IB; LaBate M; Liu F; Osterndorff E
    Mol Carcinog; 1996 Aug; 16(4):197-202. PubMed ID: 8784462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human wild-type p53 adopts a unique conformational and phosphorylation state in vivo during growth arrest of glioblastoma cells.
    Ullrich SJ; Mercer WE; Appella E
    Oncogene; 1992 Aug; 7(8):1635-43. PubMed ID: 1630823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent p53 gene mutations in serrated adenomas of the colorectum.
    Hiyama T; Yokozaki H; Shimamoto F; Haruma K; Yasui W; Kajiyama G; Tahara E
    J Pathol; 1998 Oct; 186(2):131-9. PubMed ID: 9924427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular events including p53 and k-ras alterations in the in vitro progression of a human colorectal adenoma cell line to an adenocarcinoma.
    Williams AC; Browne SJ; Yeudal WA; Paterson IC; Marshall CJ; Lane DP; Paraskeva C
    Oncogene; 1993 Nov; 8(11):3063-72. PubMed ID: 8414507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
    Sundblad AS; Chumbita RL; Zoppi JA
    Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staining patterns of p53 immunohistochemistry and their biological significance in colorectal cancer.
    Kaserer K; Schmaus J; Bethge U; Migschitz B; Fasching S; Walch A; Herbst F; Teleky B; Wrba F
    J Pathol; 2000 Mar; 190(4):450-6. PubMed ID: 10699994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
    Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
    Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Lukás J; Rejthar A; Kovarík J; Midgley CA; Gannon JV; Lane DP
    Oncogene; 1991 Sep; 6(9):1699-703. PubMed ID: 1923535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas.
    Forslund A; Kressner U; Lindmark G; Inganäs M; Lundholm K
    Int J Oncol; 2001 Sep; 19(3):501-6. PubMed ID: 11494027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
    Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
    Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression.
    de Jong KP; Gouw AS; Peeters PM; Bulthuis M; Menkema L; Porte RJ; Slooff MJ; van Goor H; van den Berg A
    Clin Cancer Res; 2005 Jun; 11(11):4067-73. PubMed ID: 15930341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.